Typicality: | 0.444 |
Saliency: | 0.454 |
for the development of antiinflammatory therapies | 5 | purpose |
for people | 5 | transitive-object |
for the mechanism of eg5 | 4 | other |
observation → have → important implications | 36 |
observation → have → the advantage | 3 |
observation → be → important contribution | 3 |
negative | neutral | positive |
0.055 | 0.666 | 0.279 |
Raw frequency | 42 |
Normalized frequency | 0.454 |
Modifier score | 0.500 |
Perplexity | 29.590 |